4//SEC Filing
Fralick Celeste Rachelle 4
Accession 0001641172-25-002185
CIK 0000926617other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:42 PM ET
Size
7.8 KB
Accession
0001641172-25-002185
Insider Transaction Report
Form 4
Fralick Celeste Rachelle
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-31−5,000→ 5,000 total→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-03-31+5,000→ 55,665 total
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0001911051
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:42 PM ET
- Size
- 7.8 KB